229 related articles for article (PubMed ID: 32041568)
1. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.
Zheng J; Ye X; Liu Y; Zhao Y; He M; Xiao H
BMC Cancer; 2020 Feb; 20(1):106. PubMed ID: 32041568
[TBL] [Abstract][Full Text] [Related]
2. Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule.
Zhong M; Zhang Y; Pan Z; Wang W; Zhang Y; Weng Y; Huang H; He Y; Liu O
Technol Cancer Res Treat; 2021; 20():15330338211041465. PubMed ID: 34519585
[No Abstract] [Full Text] [Related]
3. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
Chen X; Wang X; He H; Liu Z; Hu JF; Li W
PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
[TBL] [Abstract][Full Text] [Related]
4. [Value of Combined Detection of Cytokines and Tumor Markers in the
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
[TBL] [Abstract][Full Text] [Related]
5. Decreased levels of circulating sex hormones as a biomarker of lung cancer in male patients with solitary pulmonary nodules.
Gu T; Wen Z; Xu S; Hua H; Zhang Z; Wen T; Fu Z; Lv X
Afr Health Sci; 2014 Jun; 14(2):356-63. PubMed ID: 25320584
[TBL] [Abstract][Full Text] [Related]
6. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
Ding C; Zhou X; Xu C; Chen J; Ju S; Chen T; Liang Z; Cui Z; Li C; Zhao J
Thorac Cancer; 2018 Nov; 9(11):1413-1420. PubMed ID: 30178907
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
[TBL] [Abstract][Full Text] [Related]
9. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness.
Zhou Q; Geng Q; Wang L; Huang J; Liao M; Li Y; Ding Z; Yang S; Zhao H; Shen Q; Pan C; Lou J; Lu S; Chen C; Luo Q
EBioMedicine; 2019 Mar; 41():236-243. PubMed ID: 30872130
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.
Shen J; Liu Z; Todd NW; Zhang H; Liao J; Yu L; Guarnera MA; Li R; Cai L; Zhan M; Jiang F
BMC Cancer; 2011 Aug; 11():374. PubMed ID: 21864403
[TBL] [Abstract][Full Text] [Related]
11. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
[No Abstract] [Full Text] [Related]
12. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
Seemann MD; Beinert T; Fürst H; Fink U
Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925
[TBL] [Abstract][Full Text] [Related]
14. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
[TBL] [Abstract][Full Text] [Related]
15. Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules.
Ma G; Yang D; Li Y; Li M; Li J; Fu J; Peng Z
Thorac Cancer; 2022 Dec; 13(23):3393-3401. PubMed ID: 36284506
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study].
Lian H; Ding Z; Yuan D; Ma J; Qin J
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):813-820. PubMed ID: 27978866
[TBL] [Abstract][Full Text] [Related]
17. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
18. Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules.
Zhang W; Duan X; Zhang Z; Yang Z; Zhao C; Liang C; Liu Z; Cheng S; Zhang K
JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33905377
[TBL] [Abstract][Full Text] [Related]
19. Detection of circulating rare cells benefitted the diagnosis of malignant solitary pulmonary nodules.
Xie J; Ruan Z; Zheng J; Gong Y; Wang Y; Hu B; Cheng J; Huang Q
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2681-2692. PubMed ID: 34791530
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer.
Li J; Liao Y; Ran Y; Wang G; Wu W; Qiu Y; Liu J; Wen N; Jing T; Wang H; Zhang S
BMC Pulm Med; 2020 Oct; 20(1):274. PubMed ID: 33081780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]